Myeloid neoplasms with germline predisposition (Hereditary MDS/Acute Leukemia) (gene panel)
Full name: |
Myeloid neoplasms with germline predisposition (Hereditary MDS/Acute Leukemia) (gene panel)
|
Description: |
Targeted NGS panel including (GATA2; RUNX1; TEL (ETV6); CEBPA; ANKRD26; DDX41; TP53; TERT; TERC) |
Test type: |
Clinical
|
Test specialty: |
Molecular Genetics
|
Test purpose: |
Carrier diagnosis,
Post-natal Diagnosis,
Predictive and Pre-symptomatic diagnosis
|
Specimen: |
Peripheral (whole) blood on EDTA
|
Method category: | |
Method technique: | |
Laboratory: | |
RIZIV code: | |
Accreditation (ISO 15189): |
2022-02-24 / 2026-02-23
|
Turnaround time (maximum): |
30 days
|
Document(s): | |
Created: |
30 Aug 2019 - 10:38
|
Changed: |
23 Jan 2024 - 12:03
|